Range Cancer Therapeutics ETF (CNCR)
NASDAQ: CNCR · Real-Time Price · USD
15.22
+0.12 (0.79%)
Oct 22, 2024, 4:00 PM EDT - Market closed
CNCR Holdings List
As of Oct 18, 2024
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.91% |
2 | BMEA | Biomea Fusion, Inc. | 1.88% |
3 | TYRA | Tyra Biosciences, Inc. | 1.88% |
4 | ELVN | Enliven Therapeutics, Inc. | 1.72% |
5 | HCM | HUTCHMED (China) Limited | 1.69% |
6 | ACLX | Arcellx, Inc. | 1.57% |
7 | AURA | Aura Biosciences, Inc. | 1.56% |
8 | AUTL | Autolus Therapeutics plc | 1.51% |
9 | MGNX | MacroGenics, Inc. | 1.50% |
10 | YMAB | Y-mAbs Therapeutics, Inc. | 1.50% |
11 | KPTI | Karyopharm Therapeutics Inc. | 1.49% |
12 | DAWN | Day One Biopharmaceuticals, Inc. | 1.46% |
13 | REPL | Replimune Group, Inc. | 1.45% |
14 | RPTX | Repare Therapeutics Inc. | 1.45% |
15 | CMPX | Compass Therapeutics, Inc. | 1.45% |
16 | SNDX | Syndax Pharmaceuticals, Inc. | 1.43% |
17 | RVMD | Revolution Medicines, Inc. | 1.43% |
18 | BCYC | Bicycle Therapeutics plc | 1.43% |
19 | MRSN | Mersana Therapeutics, Inc. | 1.42% |
20 | ZYME | Zymeworks Inc. | 1.41% |
21 | GNLX | Genelux Corporation | 1.39% |
22 | EXEL | Exelixis, Inc. | 1.39% |
23 | BMY | Bristol-Myers Squibb Company | 1.39% |
24 | TSVT | 2seventy bio, Inc. | 1.38% |
25 | APLM | Apollomics, Inc. | 1.37% |
26 | MRUS | Merus N.V. | 1.37% |
27 | ARVN | Arvinas, Inc. | 1.37% |
28 | IBRX | ImmunityBio, Inc. | 1.36% |
29 | RXRX | Recursion Pharmaceuticals, Inc. | 1.36% |
30 | ALLO | Allogene Therapeutics, Inc. | 1.36% |
31 | JANX | Janux Therapeutics, Inc. | 1.35% |
32 | IOVA | Iovance Biotherapeutics, Inc. | 1.35% |
33 | IMCR | Immunocore Holdings plc | 1.35% |
34 | EXAI | Exscientia plc | 1.34% |
35 | RCUS | Arcus Biosciences, Inc. | 1.34% |
36 | NRIX | Nurix Therapeutics, Inc. | 1.34% |
37 | XNCR | Xencor, Inc. | 1.33% |
38 | ACET | Adicet Bio, Inc. | 1.33% |
39 | BPMC | Blueprint Medicines Corporation | 1.33% |
40 | IGMS | IGM Biosciences, Inc. | 1.32% |
41 | STRO | Sutro Biopharma, Inc. | 1.31% |
42 | ACRV | Acrivon Therapeutics, Inc. | 1.31% |
43 | CRBU | Caribou Biosciences, Inc. | 1.30% |
44 | GLUE | Monte Rosa Therapeutics, Inc. | 1.30% |
45 | ERAS | Erasca, Inc. | 1.29% |
46 | KYMR | Kymera Therapeutics, Inc. | 1.28% |
47 | CGEM | Cullinan Therapeutics, Inc. | 1.28% |
48 | PGEN | Precigen, Inc. | 1.24% |
49 | GERN | Geron Corporation | 1.21% |
50 | BNTX | BioNTech SE | 1.21% |
As of Oct 18, 2024